Brief: Kolinpharma Confirmed Clinical Effectiveness Of Xinepa® Integrator For Treatment Of Peripheral Neuropathies
20/03/2018 06:41
March 20 (Reuters) - Kolinpharma Spa KIP.MI :
* CONFIRMED CLINICAL EFFECTIVENESS OF XINEPA® INTEGRATOR FOR
TREATMENT OF PERIPHERAL NEUROPATHIES
Source text for Eikon: ID:nBIA5fKshH
Further company coverage: KIP.MI
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Kolinpharma SpA
See all newsBrief: Igea Holding Crosses 95% Of Kolinpharma In Context Of Takeover Bid
Brief: Kolinpharma Shareholder PRP Sells About 59.62% Of Share Capital To Igea Holding
Brief: Igea Holding Buys Additional 0.927% Of Kolinpharma Share Capital
Brief: Takeup In Takeover Bid By Igea Holding On Kolinpharma Reaches 59.411% Of Shares To Which Offer Relates
Brief: Igea Holding Buys 4.9% Of Kolinpharma Share Capital, Surpasses 90% Treshold